Market Overview: The Vietnam Viscosupplementation Market report provides a comprehensive analysis of the industry, offering an in-depth exploration of market dynamics and trends. Serving as a valuable ...

Moscow has integrated a new artificial intelligence service into its healthcare system to identify signs of hip osteoarthritis in medical images, marking the 41st modality where neural networks assist ...

In 2024, approximately 97 million diagnosed cases were reported across the 7MM, with projections indicating a rise over the ...

Dr. John Watterson, MD, FRCPC, discusses diagnosis and symptoms of osteoarthritis.

Osteoarthritis is a leading cause of chronic pain, often affecting physical function, daily activities, and quality of life.

Osteoarthritis is a leading cause of chronic pain, often affecting physical function, daily activities, and quality of life.

Published results showed a hip resurfacing implant may be an effective treatment option for younger, active men with osteoarthritis.“We studied [the implant] all along the way and to the end of ...

Estimates suggest that osteoarthritis (OA), one of the most common hip disorders, affects about 10-15 per cent of adults aged over 60 years worldwide. In the UK alone, approximately 1.4 million ...

The FDA approved viscosupplementation for osteoarthritis of the knee in 1997. There are several products on the market, one of which is a natural product made from the comb of a rooster.

Reston, J. (2020). 2019 American College of Rheumatology/Arthritis Foundation Guideline for the Management of Osteoarthritis of the Hand, Hip, and Knee. Arthritis care & research , 72 (2), 149–162.

Hip dysplasia is a developmental condition that can be congenital or occur throughout childhood and increases the risk of hip ...

Treatment of osteoarthritis depends on the severity of symptoms. Managing mild to moderate osteoarthritis typically includes information and advice, exercise plans, coping strategies, sleep management ...